CRISPR Editing Worked—But Is the Disease Model Fit for Purpose?
CRISPR has made targeted genome editing faster and more accessible, yet one persistent challenge remains: a successful on-target edit does not necessarily produce a reliable research model.   For researchers using CRISPR in disease modeling, target validation, or drug discovery, editing efficiency is only an early checkpoint. The resulting cells must also carry the intended genotype,...
0 Kommentare 0 Geteilt 94 Ansichten 0 Bewertungen
Gesponsert
Gesponsert